14-24505611-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001836.5(CMA1):c.649G>A(p.Val217Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000221 in 1,613,796 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001836.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CMA1 | NM_001836.5 | c.649G>A | p.Val217Ile | missense_variant | 5/5 | ENST00000250378.7 | NP_001827.1 | |
CMA1 | NM_001308083.2 | c.316G>A | p.Val106Ile | missense_variant | 4/4 | NP_001295012.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CMA1 | ENST00000250378.7 | c.649G>A | p.Val217Ile | missense_variant | 5/5 | 1 | NM_001836.5 | ENSP00000250378 | P1 | |
CMA1 | ENST00000206446.4 | c.316G>A | p.Val106Ile | missense_variant | 4/4 | 1 | ENSP00000206446 | |||
ENST00000555109.1 | n.144-2523C>T | intron_variant, non_coding_transcript_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.000184 AC: 28AN: 152114Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000247 AC: 62AN: 250674Hom.: 0 AF XY: 0.000229 AC XY: 31AN XY: 135434
GnomAD4 exome AF: 0.000225 AC: 329AN: 1461564Hom.: 0 Cov.: 31 AF XY: 0.000216 AC XY: 157AN XY: 727074
GnomAD4 genome AF: 0.000184 AC: 28AN: 152232Hom.: 0 Cov.: 31 AF XY: 0.000188 AC XY: 14AN XY: 74438
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 26, 2022 | The c.649G>A (p.V217I) alteration is located in exon 5 (coding exon 5) of the CMA1 gene. This alteration results from a G to A substitution at nucleotide position 649, causing the valine (V) at amino acid position 217 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at